WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004006919) MEDICINAL COMPOSITION FOR MITIGATING BLOOD LIPID OR LOWERING BLOOD HOMOCYSTEIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/006919    International Application No.:    PCT/JP2003/008674
Publication Date: 22.01.2004 International Filing Date: 08.07.2003
Chapter 2 Demand Filed:    08.07.2003    
IPC:
A61K 31/22 (2006.01), A61K 31/366 (2006.01), A61K 31/40 (2006.01), A61K 31/4415 (2006.01), A61K 31/675 (2006.01)
Applicants: SANKYO COMPANY, LIMITED [JP/JP]; 5-1, Nihonbashi Honcho 3-chome, Chuo-ku, Tokyo 103-8426 (JP) (For All Designated States Except US).
KONDO, Tatsuhito [JP/JP]; (JP) (For US Only).
TAKAGI, Ikuo [JP/JP]; (JP) (For US Only).
NAKAYAMA, Masato [JP/JP]; (JP) (For US Only).
TORIZUMI, Yasuhiro [JP/JP]; (JP) (For US Only)
Inventors: KONDO, Tatsuhito; (JP).
TAKAGI, Ikuo; (JP).
NAKAYAMA, Masato; (JP).
TORIZUMI, Yasuhiro; (JP)
Agent: OHNO, Akio; c/o Sankyo Company, Limited, 2-58, Hiromachi 1-chome, Shinagawa-ku, Tokyo 140-8710 (JP)
Priority Data:
2002-202121 11.07.2002 JP
2002-343586 27.11.2002 JP
Title (EN) MEDICINAL COMPOSITION FOR MITIGATING BLOOD LIPID OR LOWERING BLOOD HOMOCYSTEIN
(FR) COMPOSITION MEDICALE POUR REDUIRE LE TAUX DE LIPIDES SANGUINS OU LE TAUX D'HOMOCYSTEINE SANGUINE
(JA) 血中脂質改善又は血中ホモシステイン低下のための医薬組成物
Abstract: front page image
(EN)A safe drug for mitigating blood lipid and for reducing the amount of blood homocystein. It is a medicinal composition containing an HMG-CoA redactase inhibitor and a pyridoxine compound.
(FR)L'invention concerne un médicament non toxique destiné à réduire le taux de lipides sanguins et le taux d'homocystéine sanguine. Il se présente sous la forme d'une composition médicale contenant un inhibiteur de réductase HMG-CoA et un composé de pyridoxine.
(JA)[課題] 血中脂質を改善する安全な薬剤及び血中ホモシステイン量を低下させる安全な薬剤を提供すること。[解決手段] HMG−CoAリダクターゼ阻害剤とピリドキシン類とを含有する医薬組成物。
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)